References
Search
    ×

    Sepsis management

    Helping set patients at risk for sepsis on the right clinical path

    Challenges

    Sepsis is one of the most prevalent causes of death in the United States.1 As the current COVID-19 pandemic persists, we are learning that sepsis is a common complication that might be directly caused by COVID-19.2

    Sepsis is responsible for ~ 270,000 deaths in the U.S. annually 3

    100% of COVID-19 nonsurvivors had sepsis and 70% had septic shock*2

    *Based on one study

    Sepsis is the number one complication seen in COVID-19 nonsurvivors 2

    You are faced with sepsis and COVID-19 challenges and we are here to support you

    Let's talk

    THE BD PATH FOR SEPSIS MANAGEMENT

    When it comes to patients at risk for sepsis, time to appropriate therapy is critical

    By reducing time from recognition to accurate identification and treatment,
    you are setting them on the right clinical path. Our sepsis management program can help.

    Approach

    Goals

    Learn how we can support your sepsis initiatives.

    Download program

    SEPSIS CARE APPROACH

    BD? Sepsis Management Program—from initial recognition to treatment

    Recognize

    Mortality from septic shock increases 7.6% for every hour that treatment is delayed4 among patients with septic shock within the first 6 hours of onset of hypotension.

    The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment.

    Discover our solution:

    BD HealthSight™ Clinical Advisor and Infection Advisor »

    Prep

    ~ 80% of skin flora reside in the first five layers of our outermost skin5

    Proper skin preparation kills bacteria on the skin that can potentially cause skin infection and contamination.

    Discover our solution:

    BD ChloraPrep? Swabstick »

    Collect

    ~ 20% of blood culture samples have been reported as underfilled in the U.S.6

    Support optimal blood culture specimen collection; sufficient blood volume is a critical determinant for optimal organism recovery. The yield of pathogens recovered increases in direct proportion to the volume of blood cultured. 6

    Discover our solution:

    BD Vacutainer? UltraTouch? Push Button Blood Collection Set »

    Analyze

    80% of sepsis deaths could be prevented by quicker diagnosis and treatment7

    Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching.8

    Discover our solutions:

    BD BACTEC? Blood Culture Media »

    BD BACTEC? FX Instruments »

    BD Kiestra? Lab Automation System »

    BD Phoenix? Automated Identification and Susceptibility Testing System »

    BD Synapsys? Microbiology Informatics Solution »

    Treat

    5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients9

    Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.

    Discover our solutions:

    BD HealthSight? Clinical Advisor »

    BD Phoenix? Automated Identification and Susceptibility Testing »

    Medication management solutions »

     
    1. Recognize
    2. Prep
    3. Collect
    4. Analyze
    5. Treat
    Contact Us

    Do you want to learn more about how we can support your sepsis initiatives?

    Proud to support efforts in sepsis awareness and care


     References
    1. Sepsis takes more lives than opioid overdoses, but most adults don’t know. September 3, 2019. Accessed August 21, 2020. https://www.sepsis.org/news/2019-sepsis-awareness-survey/.
    2. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3.
    3. Data & Reports. Centers for Disease Control and Prevention. 2020. Accessed August 21, 2020. https://www.cdc.gov/sepsis/datareports/index.html
    4. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.
    5. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis. 1989;160(4):644-650.
    6. Lamy B, Dargère S, Arendrup MC, Parienti J-J, Tattevin P. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol. 2016;7:697.
    7. Sepsis Alliance. Sepsis fact sheet, 2018. Accessed August 21, 2020.
    8. Kerremans JJ, van der Bij AK, Goessens W, Verbrugh HA, Vos MC. Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching. J Clin Microbiol. 2009;47(11):3520-3523.
    9. Kumar A, Ellis P, Aribi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237-1248.

    Approach

    Let’s collaborate to optimize how you manage patients across the sepsis care pathway using BD solutions. The approach will include:

    1. Aligning metrics to your initiatives
    2. Establishing a baseline with an assessment
    3. Identifying areas of improvement across people, processes and technologies
    4. Sustaining best practices through hospital champions, performance dashboards and ongoing education and training of BD solutions
    ×

    Goals

    By focusing on the sepsis care pathway—from recognition of patients at-risk for sepsis through their treatment—using BD solutions, you can start on the journey of:

    • Reducing time to recognition of patients at risk for sepsis
    • Improving blood culture collection and optimizing diagnostic accuracy
    • Reducing time to detection and lab turnaround time

    With the ultimate goal of reducing time to appropriate therapy and improving patient outcomes.

    ×
    奔驰宝马破解版无限金币 东方6 1生肖走势图 腾讯分分彩全能版必中计划 秒速赛车大小单双计划 河北十一选五推荐 河北11选五助手老版本 36选7好彩1奖金 环岛赛体彩开奖结果 七星彩重新开奖确切时间 山西省体彩11选五 甘肃十一选五万能码 上海11选5网址 甘肃十一选五遗漏五码分布走 秒速飞艇全部开奖记录 无本一个星期赚10万 深圳配资平台都有哪些 专业配资网